VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRVSCorvus Pharmaceuticals, Inc.
$14.48$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRVSQuarterly Financials

Corvus Pharmaceuticals, Inc. (CRVS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Corvus Pharmaceuticals, Inc. (CRVS) quarterly income statement — complete revenue, gross profit & net income history

CRVS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold29K26K000000000000000000
COGS % of Revenue--------------------
Gross Profit-29K-26K000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses14.88M12.19M10.57M10.26M9.92M8.11M7.25M5.93M6.25M5.65M5.56M5.62M6.57M5.67M12.47M7.01M7.41M6.81M9.05M11.29M
OpEx % of Revenue--------------------
Selling, General & Admin3.7M2.28M2.12M2.39M2.47M2.13M2.03M1.82M2.18M1.65M1.59M1.65M1.98M1.59M2.11M2.09M2.31M2.02M2.06M2.18M
SG&A % of Revenue--------------------
Research & Development11.18M9.94M8.45M7.87M7.45M5.97M5.22M4.11M4.08M4M3.96M3.97M4.59M4.08M10.37M4.92M5.1M4.79M6.99M9.11M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-14.88M-12.22M-10.57M-10.26M-9.92M-8.11M-7.25M-5.93M-6.25M-5.65M-5.56M-5.62M-6.57M-5.67M-12.47M-7.01M-7.41M-6.81M-9.05M-11.29M
Operating Margin %--------------------
Operating Income Growth %-49.94%-50.73%-45.72%-72.87%-58.68%-43.43%-30.49%-5.57%4.88%0.26%55.42%19.83%11.32%16.8%-37.87%37.88%35.44%31.07%8.11%-4.86%
EBITDA-14.85M-12.19M-10.54M-10.23M-9.9M-8.09M-7.23M-5.91M-6.23M-5.62M-5.53M-5.59M-6.52M-5.57M-12.38M-6.92M-7.33M-6.72M-8.94M-11.17M
EBITDA Margin %--------------------
EBITDA Growth %-49.98%-50.79%-45.76%-73%-58.91%-43.78%-30.81%-5.87%4.4%-0.92%55.33%19.29%11.04%17.05%-38.48%38.03%35.43%31.02%7.83%-5.28%
D&A (Non-Cash Add-back)29K26K28K29K22K20K21K21K23K28K30K36K57K94K94K92K87K93K108K122K
EBIT-14.88M-12.22M-10.16M-10.26M-9.92M-8.11M-7.25M-5.93M-6.25M-5.65M-5.56M-5.62M-6.57M-5.67M-12.47M-7.01M-7.41M-9.23M-10.66M-11.29M
Net Interest Income-1.78M-1.9M738K639K525K508K566K434K316K380K425K403K376K318K225K100K11K-8K-11K1K
Interest Income0-1.9M738K639K525K508K566K434K316K380K425K403K376K318K225K100K11K001K
Interest Expense1.78M00000000000000008K11K0
Other Income/Expense1.19M-104K415K2.26M25.11M-4.01M-32.96M1.67M552K-1M-440K-881K-1.3M-4.15M-2.36M-1.35M-884K-2.43M-1.63M-462K
Pretax Income-13.69M-12.32M-10.16M-8M15.19M-12.11M-40.22M-4.26M-5.7M-6.65M-6M-6.5M-7.87M-9.82M-14.83M-8.36M-8.3M-9.24M-10.67M-11.75M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-13.69M-12.32M-10.16M-8M15.19M-12.11M-40.22M-4.26M-5.7M-6.65M-6M-6.5M-7.87M-9.82M-14.83M-8.36M-8.3M-9.24M-10.67M-11.75M
Net Margin %--------------------
Net Income Growth %-190.12%-1.72%74.74%-87.66%366.5%-82.07%-570.28%34.46%27.59%32.22%59.54%22.24%5.11%-6.28%-38.96%28.84%28.35%-133.77%-8.95%-10.75%
Net Income (Continuing)-13.69M-12.32M-10.16M-8M15.19M-12.11M-40.22M-4.26M-5.7M-6.65M-6M-6.5M-7.87M-9.82M-14.83M-8.36M-8.3M-9.24M-10.67M-11.75M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.15-0.18-0.12-0.10-0.13-0.18-0.60-0.07-0.12-0.14-0.12-0.14-0.17-0.21-0.32-0.18-0.18-0.20-0.24-0.28
EPS Growth %-15.38%0%80%-42.86%-8.33%-32.65%-400%50%29.41%35.38%62.5%22.22%5.56%-5%-33.33%35.71%47.06%-121.74%27.27%22.22%
EPS (Basic)-0.15-0.18-0.12-0.100.21-0.18-0.60-0.07-0.12-0.14-0.12-0.14-0.17-0.21-0.32-0.18-0.18-0.20-0.24-0.28
Diluted Shares Outstanding90M79.74M82.84M77.77M75.15M68.35M66.7M59.71M49.04M49.04M48.97M47.5M46.56M46.55M46.55M46.55M46.55M46.55M43.95M42.25M
Basic Shares Outstanding90M78.96M82.84M77.77M72.13M68.35M66.7M59.71M49.04M49.04M48.97M47.5M46.56M46.55M46.55M46.55M46.55M46.55M43.95M42.25M
Dividend Payout Ratio--------------------